Author： Uto Yoshikazu
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.1, 2012-01, pp. : 89-93
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
A small series of piperidine analogs that effectively activate glycogen synthase (GS) was prepared in WO2011058122. The treatment or prophylaxis of metabolic disease and disorders by these novel GS activators is claimed. These compounds represent further variations around a structural motif explored in the prior patent publications by Roche.
Related content
Access to resources
Recommend
Polymyxin derivatives: a patent evaluation (WO2012168820)
By Wu Haifan
Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. :